SG11201805394QA - Treatment of hand eczema - Google Patents
Treatment of hand eczemaInfo
- Publication number
- SG11201805394QA SG11201805394QA SG11201805394QA SG11201805394QA SG11201805394QA SG 11201805394Q A SG11201805394Q A SG 11201805394QA SG 11201805394Q A SG11201805394Q A SG 11201805394QA SG 11201805394Q A SG11201805394Q A SG 11201805394QA SG 11201805394Q A SG11201805394Q A SG 11201805394QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- treatment
- ballerup
- pct
- hand eczema
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Storage Of Fruits Or Vegetables (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16152215 | 2016-01-21 | ||
| PCT/EP2017/051133 WO2017125523A1 (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805394QA true SG11201805394QA (en) | 2018-08-30 |
Family
ID=55236207
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805394QA SG11201805394QA (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
| SG10202006830WA SG10202006830WA (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202006830WA SG10202006830WA (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20200397787A1 (uk) |
| EP (2) | EP4257205A3 (uk) |
| JP (1) | JP6929860B2 (uk) |
| KR (1) | KR20180102662A (uk) |
| CN (3) | CN117159554A (uk) |
| AU (2) | AU2017209932A1 (uk) |
| BR (1) | BR112018014769A2 (uk) |
| CA (1) | CA3010547A1 (uk) |
| DK (1) | DK3405197T3 (uk) |
| ES (1) | ES2963784T3 (uk) |
| FI (1) | FI3405197T3 (uk) |
| HR (1) | HRP20231448T1 (uk) |
| HU (1) | HUE064192T2 (uk) |
| IL (2) | IL297379A (uk) |
| LT (1) | LT3405197T (uk) |
| MX (2) | MX2018008449A (uk) |
| PL (1) | PL3405197T3 (uk) |
| PT (1) | PT3405197T (uk) |
| RS (1) | RS64798B1 (uk) |
| RU (1) | RU2018130097A (uk) |
| SG (2) | SG11201805394QA (uk) |
| SI (1) | SI3405197T1 (uk) |
| TW (1) | TWI783921B (uk) |
| UA (1) | UA123780C2 (uk) |
| WO (1) | WO2017125523A1 (uk) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3968997A1 (en) * | 2019-05-15 | 2022-03-23 | Leo Pharma A/S | Treatment of cutaneous lupus erythematosus |
| WO2022167913A1 (en) * | 2021-02-02 | 2022-08-11 | Pfizer Inc. | Dosing regime for treatment of chronic hand eczema |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI466885B (zh) * | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| US20130302298A1 (en) * | 2010-11-30 | 2013-11-14 | Bio-K Plus International Inc. | Treatment and prevention of eczema |
| US20140343034A1 (en) * | 2013-04-25 | 2014-11-20 | Japan Tobacco Inc. | Skin barrier function improving agent |
-
2017
- 2017-01-20 HR HRP20231448TT patent/HRP20231448T1/hr unknown
- 2017-01-20 DK DK17701828.0T patent/DK3405197T3/da active
- 2017-01-20 FI FIEP17701828.0T patent/FI3405197T3/fi active
- 2017-01-20 WO PCT/EP2017/051133 patent/WO2017125523A1/en active Application Filing
- 2017-01-20 EP EP23195420.7A patent/EP4257205A3/en active Pending
- 2017-01-20 RU RU2018130097A patent/RU2018130097A/ru unknown
- 2017-01-20 AU AU2017209932A patent/AU2017209932A1/en not_active Abandoned
- 2017-01-20 PT PT177018280T patent/PT3405197T/pt unknown
- 2017-01-20 RS RS20231010A patent/RS64798B1/sr unknown
- 2017-01-20 CN CN202311350784.6A patent/CN117159554A/zh active Pending
- 2017-01-20 BR BR112018014769-9A patent/BR112018014769A2/pt active Search and Examination
- 2017-01-20 JP JP2018538167A patent/JP6929860B2/ja active Active
- 2017-01-20 HU HUE17701828A patent/HUE064192T2/hu unknown
- 2017-01-20 SI SI201731440T patent/SI3405197T1/sl unknown
- 2017-01-20 PL PL17701828.0T patent/PL3405197T3/pl unknown
- 2017-01-20 US US16/071,209 patent/US20200397787A1/en not_active Abandoned
- 2017-01-20 KR KR1020187024112A patent/KR20180102662A/ko active Search and Examination
- 2017-01-20 MX MX2018008449A patent/MX2018008449A/es unknown
- 2017-01-20 SG SG11201805394QA patent/SG11201805394QA/en unknown
- 2017-01-20 CN CN201780006075.2A patent/CN108472297A/zh active Pending
- 2017-01-20 EP EP17701828.0A patent/EP3405197B1/en active Active
- 2017-01-20 ES ES17701828T patent/ES2963784T3/es active Active
- 2017-01-20 CA CA3010547A patent/CA3010547A1/en active Pending
- 2017-01-20 LT LTEPPCT/EP2017/051133T patent/LT3405197T/lt unknown
- 2017-01-20 UA UAA201808829A patent/UA123780C2/uk unknown
- 2017-01-20 SG SG10202006830WA patent/SG10202006830WA/en unknown
- 2017-01-20 CN CN202311350781.2A patent/CN117159553A/zh active Pending
- 2017-01-20 IL IL297379A patent/IL297379A/en unknown
- 2017-01-20 TW TW106102111A patent/TWI783921B/zh active
-
2018
- 2018-06-18 IL IL260094A patent/IL260094A/en unknown
- 2018-07-09 MX MX2022005915A patent/MX2022005915A/es unknown
-
2022
- 2022-07-08 US US17/811,347 patent/US20230138114A1/en active Pending
- 2022-10-13 AU AU2022252766A patent/AU2022252766A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201908670SA (en) | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201809082WA (en) | Nlrp3 modulators | |
| SG11201809751XA (en) | Egfr inhibitor compounds | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201908786VA (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| SG11201408095XA (en) | Fibroblast growth factor 21 proteins | |
| SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
| SG11201908465QA (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| SG11201408044QA (en) | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS | |
| SG11201408318RA (en) | Compositions and methods for transmucosal absorption | |
| SG11201808270PA (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| SG11201908512YA (en) | Somatostatin modulators and uses thereof | |
| SG11201808138YA (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
| SG11201907804QA (en) | Pharmaceutical composition comprising selexipag | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201811671XA (en) | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof | |
| SG11201908097YA (en) | Pyrimidine derivatives as pge2 receptor modulators | |
| SG11201808686VA (en) | Synthesis of indazoles | |
| SG11201909680UA (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201900238UA (en) | Compounds and methods for modulation of smn2 | |
| SG11201407345QA (en) | Pyrazole compounds as sglt1 inhibitors |